QIAGEN NV

53
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0015001WM6
USD
41.54
0.62 (1.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
QIAGEN NV Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
490.00
121.00
429.00
512.00
625.00
439.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-34.00
135.00
-186.00
-31.00
-130.00
-72.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
654.00
673.00
459.00
715.00
639.00
457.00
Cash Flow from Investing Activities
-305.00
-249.00
-87.00
-726.00
-202.00
-443.00
Cash Flow from Financing Activities
-178.00
-422.00
-433.00
-125.00
-150.00
-50.00
Net Cash Inflow / Outflow
175.00
-4.00
-62.00
-149.00
282.00
-31.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
5.00
-5.00
0.00
-12.00
-3.00
4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of QIAGEN NV
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
490.265
22
468.00
2128.48%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-34.513
-144.8
110.00
76.17%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
654.326
134.1
520.00
387.94%
Cash Flow from Investing Activities
-305.279
-196.5
-109.00
-55.36%
Cash Flow from Financing Activities
-178.976
135.1
-313.00
-232.48%
Net Cash Inflow / Outflow
175.45
116.4
59.00
50.73%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
5.379
43.7
-38.00
-87.69%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -2.85% vs 46.60% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
654.33
673.55
-2.85%